UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib with continuous schedule vs cediranib-olaparib with intermittent schedule in advanced platinum resistant ovarian cancer

Annals of oncology, 2018-10, Vol.29, p.viii357-viii357

2018

Volltextzugriff (PDF)

Protection From Arthritis and Myositis in a Mouse Model of Acute Chikungunya Virus Disease by Bindarit, an Inhibitor of Monocyte Chemotactic Protein-1 Synthesis

The Journal of infectious diseases, 2011-10, Vol.204 (7), p.1026-1030

2011

Volltextzugriff (PDF)

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

Annals of oncology, 2017-12, Vol.28 (12), p.3110-3110

2017

Volltextzugriff (PDF)

TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma Group

ESMO open, 2024-08, Vol.9 (8), p.103667, Article 103667

2024

Volltextzugriff (PDF)

Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study

ESMO open, 2022-06, Vol.7 (3), p.100469-100469, Article 100469

2022

Volltextzugriff (PDF)

Identification and Characterization of a Ross River Virus Variant That Grows Persistently in Macrophages, Shows Altered Disease Kinetics in a Mouse Model, and Exhibits Resistance to Type I Interferon

Journal of Virology, 2011-06, Vol.85 (11), p.5651-5663

2011

Volltextzugriff (PDF)

Germline variants and clinical outcomes of high-risk stage II and stage III colon cancer patients treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy: a pharmacogenetic ancillary study to TOSCA trial

Annals of oncology, 2017-10, Vol.28, p.vi3-vi4

2017

Volltextzugriff (PDF)

FOLFOX4/XELOX in stage II–III colon cancer: early survival data of the Italian Three Or Six Colon Adjuvant (TOSCA) trial

Annals of oncology, 2017-10, Vol.28, p.vi1-vi1

2017

Volltextzugriff (PDF)

PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers

ESMO open, 2022-12, Vol.7 (6), p.100645, Article 100645

2022

Volltextzugriff (PDF)

Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma

ESMO open, 2022-12, Vol.7 (6), p.100644, Article 100644

2022

Volltextzugriff (PDF)

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?

International journal of breast cancer, 2017-01, Vol.2017 (2017), p.1-6

2017

Volltextzugriff (PDF)

2006 A phase III multicenter trial comparing two different sequences of second/third line therapy (cetuximab/irinotecan followed by FOLFOX versus FOLFOX followed by cetuximab/irinotecan) in metastatic K-RAS wt colorectal cancer (mCC) patients, refractory to FOLFIRI/Bevacizumab

European journal of cancer (1990), 2015-09, Vol.51, p.S329-S329

2015

Volltextzugriff (PDF)

Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy

ESMO open, 2021-02, Vol.6 (1), p.100034-100034, Article 100034

2021

Volltextzugriff (PDF)

Performance of imaging modalities in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis

Ultraschall in der Medizin, 2013-10, Vol.34 (5), p.454-462

2013

Volltextzugriff (PDF)

Assessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint

British journal of cancer, 2018-12, Vol.119 (12), p.1456-1463

2018

Volltextzugriff (PDF)

Downregulation of Interferon-β in Antibody-Dependent Enhancement of Dengue Viral Infections of Human Macrophages Is Dependent on Interleukin-6

The Journal of infectious diseases, 2011-08, Vol.204 (3), p.489-491

2011

Volltextzugriff (PDF)

Disease exacerbation by etanercept in a mouse model of alphaviral arthritis and myositis

Arthritis & rheumatology (Hoboken, N.J.), 2011-02, Vol.63 (2), p.488-491

2011

Volltextzugriff (PDF)

The molecular and cellular aspects of arthritis due to alphavirus infections: lesson learned from Ross River virus

Annals of the New York Academy of Sciences, 2007-04, Vol.1102 (1), p.96-108

2007

Volltextzugriff (PDF)

The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis

Annals of oncology, 2019-10, Vol.30, p.v554-v555

2019

Volltextzugriff (PDF)

1359P - The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis

Annals of oncology, 2019-10, Vol.30, p.v554-v555

2019

Volltextzugriff (PDF)

1359PThe impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Ross River virus: molecular and cellular aspects of disease pathogenesis

Pharmacology & therapeutics (Oxford), 2005-09, Vol.107 (3), p.329-342

2005

Volltextzugriff (PDF)

1143 POSTER KRAS Mutational Status Strongly Impact Progression Free Survival of Patients Treated With Platinum Based Chemotherapy in NSCLC -Final Results of a Multicenter Prospective Study

European journal of cancer (1990), 2011, Vol.47, p.S137-S137

2011

Volltextzugriff (PDF)

Biological Characteristics and Medical Treatment of Breast Cancer in Young Women-A Featured Population: Results from the NORA Study

International Journal of Breast Cancer, 2011-01, Vol.2011 (2011), p.168-173

2011

Volltextzugriff (PDF)

26 – 50 von 304

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(214)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(114)
Science & Technology
(99)
Life Sciences & Biomedicine
(91)
Female
(51)
Male
(47)
Middle Aged
(47)
Oncology
(40)
Adult
(37)
Aged
(33)
Animals
(32)
Biological And Medical Sciences
(29)
Medical Sciences
(25)
Aged, 80 And Over
(17)
Old Medline
(14)
Mice
(12)
Tumors
(12)
Treatment Outcome
(11)
Surgery
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(9)
Cancer Research
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

BAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib with continuous schedule vs cediranib-olaparib with intermittent schedule in advanced platinum resistant ovarian cancer

Protection From Arthritis and Myositis in a Mouse Model of Acute Chikungunya Virus Disease by Bindarit, an Inhibitor of Monocyte Chemotactic Protein-1 Synthesis

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

TRAbectedin in adVanced rEtroperitoneal well differentiated/dedifferentiated Liposarcoma and Leiomyosarcoma (TRAVELL): results of a phase II study from the Italian Sarcoma Group

Acral lentiginous melanoma histotype predicts outcome in clinical stage I-II melanoma patients: an International multicenter study

Identification and Characterization of a Ross River Virus Variant That Grows Persistently in Macrophages, Shows Altered Disease Kinetics in a Mouse Model, and Exhibits Resistance to Type I Interferon

Germline variants and clinical outcomes of high-risk stage II and stage III colon cancer patients treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy: a pharmacogenetic ancillary study to TOSCA trial

FOLFOX4/XELOX in stage II–III colon cancer: early survival data of the Italian Three Or Six Colon Adjuvant (TOSCA) trial

PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers

Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma

Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now?

2006 A phase III multicenter trial comparing two different sequences of second/third line therapy (cetuximab/irinotecan followed by FOLFOX versus FOLFOX followed by cetuximab/irinotecan) in metastatic K-RAS wt colorectal cancer (mCC) patients, refractory to FOLFIRI/Bevacizumab

Single-arm, open label prospective trial to assess prediction of the role of ERCC1/XPF complex in the response of advanced NSCLC patients to platinum-based chemotherapy

Performance of imaging modalities in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis

Assessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint

Downregulation of Interferon-β in Antibody-Dependent Enhancement of Dengue Viral Infections of Human Macrophages Is Dependent on Interleukin-6

Disease exacerbation by etanercept in a mouse model of alphaviral arthritis and myositis

The molecular and cellular aspects of arthritis due to alphavirus infections: lesson learned from Ross River virus

The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis

1359P - The impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis

1359PThe impact of targeted therapies and immunotherapy in melanoma brain metastases: A systematic review and meta-analysis

Ross River virus: molecular and cellular aspects of disease pathogenesis

1143 POSTER KRAS Mutational Status Strongly Impact Progression Free Survival of Patients Treated With Platinum Based Chemotherapy in NSCLC -Final Results of a Multicenter Prospective Study

Biological Characteristics and Medical Treatment of Breast Cancer in Young Women-A Featured Population: Results from the NORA Study

Suchergebnisse filtern